SA PRO
Free Account
ZBIOZBIO
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 80% recommend buying.

Consensus Rating
Buy
5 analysts·Limited coverage
80%
Rating Distribution
Strong Buy
00%
Buy
480%
Hold
120%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 103% higher.

Bear Case
$19.00
+4%
Consensus
$37.00
+103%
Bull Case
$48.00
+164%
Price Range5 analysts
Low
Consensus
High
$19.00
$48.00
Current Target
Current Price
$18.19
Upside to Target
$18.81

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 6, 2026Jefferies
Zenas Biopharma (ZBIO) PT Lowered to $48 at Jefferies, 'we see clear path for approval (BLA submission planned in 2Q and MAA in 2H26')
Target:$48.00
+189.0%from $16.61
Jan 5, 2026Morgan Stanley
Zenas BioPharma downgraded to Equal Weight from Overweight at Morgan Stanley
Target:$19.00
+14.4%from $16.61
Oct 28, 2025H.C. Wainwright
Zenas BioPharma price target raised to $44 from $30 at H.C. Wainwright
Target:$44.00
+48.3%from $29.67
Oct 27, 2025Morgan Stanley
Zenas Biopharma (ZBIO) PT Raised to $34 at Morgan Stanley
Target:$34.00
+7.4%from $31.65
Oct 27, 2025Jefferies
Zenas Biopharma (ZBIO) PT Raised to $52 at Jefferies
Target:$52.00
+63.5%from $31.80
Oct 8, 2024Jefferies
Zenas BioPharma initiated with a Buy at Jefferies
Target:$35.00
+87.2%from $18.70

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance